论文部分内容阅读
慢心律(mexiletine)是一种新的抗心律失常药。动物实验及临床应用证明,该药对多种原因引起的室性心律失常疗效较好。我们在临床使用过程中发现,该药对室上性心律失常亦有良好疗效。现将我们应用慢心律治疗54例63次室上性心律失常的疗效观察报告如下。
Mexiletine is a new antiarrhythmic drug. Animal experiments and clinical applications show that the drug for a variety of causes of ventricular arrhythmias better. We found in clinical use, the drug has a good effect on supraventricular arrhythmias. Now we use slow heart rate treatment of 54 cases of 63 cases of supraventricular arrhythmia report is as follows.